Assay Detail
Binding
CHEMBL5734960
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Measurement of Biochemical Activity of Compounds: In order to assess the activity of chemical compounds against the relevant kinase of interest, the Caliper LifeSciences electrophoretic mobility shift technology platform was used. Fluorescently labeled substrate peptide was incubated in the presence of kinase and ATP so that a reflective proportion of the peptide was phosphorylated. At the end of the reaction, the mix of phosphorylated (product) and non-phosphorylated (substrate) peptides were passed through the microfluidic system of the Caliper EZ Reader 2, under an applied potential difference. The presence of the phosphate group on the product peptide provides a difference in mass and charge between those of the substrate peptide, resulting in a separation of the substrate and product pools in the sample. As the pools pass a LEDS within the instrument, these pools are detected and resolved as separate peaks. The ratio between these peaks therefore reflects the activity of the chemical matter at that concentration in that well, under those conditions.
12
Total Activities
4
Compounds Tested
3
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Target
Proto-oncogene tyrosine-protein kinase receptor Ret (CHEMBL2041) ↗| Type | SINGLE PROTEIN |
| Organism | Homo sapiens |
Publication
Inhibitors of RET
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 4 | 8.10 | 8.40 |
| kon | 4 | - | - |
| k_off | 4 | - | - |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL24828 | VANDETANIB | 4.0 | 3 | 8.40 |
| CHEMBL1336 | SORAFENIB | 4.0 | 3 | 8.10 |
| CHEMBL2105717 | CABOZANTINIB | 4.0 | 3 | 7.96 |
| CHEMBL1946170 | REGORAFENIB | 4.0 | 3 | 7.92 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL24828 | VANDETANIB | IC50 | = | 4.0 | nM | 8.40 |
| CHEMBL1336 | SORAFENIB | IC50 | = | 7.9 | nM | 8.10 |
| CHEMBL2105717 | CABOZANTINIB | IC50 | = | 11.0 | nM | 7.96 |
| CHEMBL1946170 | REGORAFENIB | IC50 | = | 12.0 | nM | 7.92 |
| CHEMBL2105717 | CABOZANTINIB | kon | = | - | — | - |
| CHEMBL2105717 | CABOZANTINIB | k_off | = | - | s-1 | - |
| CHEMBL24828 | VANDETANIB | kon | = | - | — | - |
| CHEMBL24828 | VANDETANIB | k_off | = | - | s-1 | - |
| CHEMBL1336 | SORAFENIB | kon | = | - | — | - |
| CHEMBL1336 | SORAFENIB | k_off | = | - | s-1 | - |
| CHEMBL1946170 | REGORAFENIB | kon | = | - | — | - |
| CHEMBL1946170 | REGORAFENIB | k_off | = | - | s-1 | - |